{"url_path":"/sec/exoz/8-k/2026-06-08/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-08","source_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-027688-index.html","accession_number":"0001493152-26-027688","cik":"0002010788","ticker":"EXOZ","issuer_name":"EXOZYMES INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-027688-index.html","primary_entity_key":"0002010788","primary_entity_name":"EXOZYMES INC."},"word_count":103,"has_tables":true,"body_markdown":"**Item\n7.01**\n**Regulation\nFD Disclosure**\n\n \n\nOn\nJune 8, 2026, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is furnished as\nExhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.\n\n \n\nThe\ninformation contained in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange\nAct of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act, or the\nExchange Act, except as shall be expressly set forth by specific reference in such a filing."}